Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annu...(ents. COMPANY CONTACT: Vion Pha...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting
Date:12/4/2008
ents.
COMPANY CONTACT: Vion Pharmaceuticals, Inc.
Alan Kessman, Chief Executive Officer
Howard B. Johnson, President & CFO
(203) 498-4210 phone
'/>"/>
| SOURCE Vion Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3
[0] Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery[0] Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project[0] Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer[0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Other Biology Technology:Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 2Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 3Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 4Optimizing the Direct Amplification of Missing cDNA 5' Ends, Using the Eppendorf Mastercycler gradient 5Optimized Dengue RT-PCR 2Optimized Dengue RT-PCR 3The use of TaqMaster PCR Enhancer 2The use of TaqMaster PCR Enhancer 3The use of TaqMaster PCR Enhancer 4The use of TaqMaster PCR Enhancer 5
Breaking Biology News(10 mins):Type 2 diabetes gene predisposes children to obesity 2Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences 2New understanding of how to prevent destruction of a tumor suppressor 2New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 62557 1New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 62557 2New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 62557 3New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 62557 4MEDRAD Demonstrates PACS Injection Record Integration at RSNA 2009 6738 1MEDRAD Demonstrates PACS Injection Record Integration at RSNA 2009 6738 2MEDRAD Demonstrates PACS Injection Record Integration at RSNA 2009 6738 3Harmful Procedures on Young Women Caused by Outdated HPV test not by Pap Test 62552 1Harmful Procedures on Young Women Caused by Outdated HPV test not by Pap Test 62552 2
Other Biology News:Brains can recover from alcoholic damage but patients should stop drinking as soon as possible 2Brains can recover from alcoholic damage but patients should stop drinking as soon as possible 3Brains can recover from alcoholic damage but patients should stop drinking as soon as possible 4Professors to develop hand-held pathogen testing device 2Cardiologist's 'living chip' changes science of disease monitoring 2Cardiologist's 'living chip' changes science of disease monitoring 3Cardiologist's 'living chip' changes science of disease monitoring 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |